The Evolut FX TAVR system is used for treatment of symptomatic severe aortic stenosis and it has features that enhance ease-of-use and predictable valve deployment
Filing for WHO Emergency Use Authorisation this month
The company is doubling its chemistry research capacity that should commission by Q2'FY22
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
India sales grew 23.5% YoY with consolidation of Wockhardt products
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
_256_384.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
India business grew 11.8% YoY vs mid-single digit industry growth.
Subscribe To Our Newsletter & Stay Updated
